(Q46494673)

22 December 2017

title

Incretin and islet hormonal responses to fat and protein ingestion in healthy men. (English)

1 reference

22 December 2017

Carolyn F Deacon

6

0 references

Bo Ahrén

7

object named as

Bo Ahrén

1 reference

22 December 2017

author name string

Richard D Carr

1

1 reference

22 December 2017

Marianne O Larsen

2

1 reference

22 December 2017

Maria Sörhede Winzell

3

1 reference

22 December 2017

Katarina Jelic

4

1 reference

22 December 2017

Ola Lindgren

5

1 reference

22 December 2017

publication date

8 July 2008

1 reference

22 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

22 December 2017

volume

295

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

E779-84

1 reference

22 December 2017

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

New developments in the incretin concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

What do we know about the secretion and degradation of incretin hormones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Nutrient, neural and endocrine control of glucagon-like peptide secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Fatty acid signaling in the beta-cell and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

The gastrointestinal tract and glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

Pharmacodynamics of Vildagliptin in Patients With Type 2 Diabetes During OGTT

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90233.2008

10.1152/AJPENDO.90233.2008

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18612044

1 reference

22 December 2017